GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » Deferred Policy Acquisition Costs

Vaxil Bio (TSXV:VXL) Deferred Policy Acquisition Costs


View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Vaxil Bio (TSXV:VXL) Business Description

Industry
Traded in Other Exchanges
Address
C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.